SCHEMBL436298

SCHEMBL436298

CN(C)C(=O)N(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL29112727 0.91 FFAR3 (0.41)
SCHEMBL25474034 0.85
SCHEMBL4761502 0.79 ALDH1A1 (0.39)
SCHEMBL28423362 0.79
SCHEMBL24760 0.76
SCHEMBL6523333 0.76 ALDH1A1 (0.50)
Propane SCHEMBL28126878 0.76 ALDH1A1 (0.32)
SCHEMBL28094883 0.73 ALDH1A1 (0.35)
SCHEMBL28210212 0.73 PHF8 (0.35)
Hydrochloric Acid SCHEMBL31267456 0.72 ALDH1A1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114945373-B Parenteral nutrition preparation and preparation method thereof 德国生物分子研究公司 2024-02-06 CN disclosed
CN-111163763-B Method for inhibiting conversion of choline to Trimethylamine (TMA) 宝洁公司 2023-08-22 CN disclosed
CN-111163765-B Method for inhibiting conversion of choline to Trimethylamine (TMA) 宝洁公司 2023-05-09 CN disclosed
EP-3367994-B1 METHOD FOR INHIBITING OR MASKING FISHY ODOURS SYMRISE AG (DE) 2021-05-12 EP disclosed
WO-2020117942-A1 CHOLINE METABOLISM INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-06-11 WO disclosed
US-20160220694-A1 Vitamin-Receptor Binding Drug Delivery Conjugates ENDOCYTE INC (US) 2016-08-04 US disclosed
US-8765096-B2 Methods and compositions for treating and diagnosing kidney disease ENDOCYTE, INC (US) 2014-07-01 US disclosed
US-8765096-B2 Methods and compositions for treating and diagnosing kidney disease ENDOCYTE, INC (US) 2014-07-01 US disclosed
US-20140058063-A1 VITAMIN RECEPTOR BINDING DRUG DELIVERY CONJUGATES ENDOCYTE, INC. (US) 2014-02-27 US disclosed
US-20140058063-A1 VITAMIN RECEPTOR BINDING DRUG DELIVERY CONJUGATES ENDOCYTE, INC. (US) 2014-02-27 US disclosed
US-20100137314-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-03 US disclosed
US-20100104626-A1 METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING KIDNEY DISEASE ENDOCYTE, INC. (US) 2010-04-29 US disclosed
US-20100099692-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-22 US disclosed
US-20100099692-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-22 US disclosed
US-20100099692-A1 HARMFUL ORGANISM CONTROL COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-22 US disclosed
US-20100004276-A1 VITAMIN RECEPTOR BINDING DRUG DELIVERY CONJUGATES VLAHOV IONTCHO R 2010-01-07 US disclosed
US-7601332-B2 Minimized toxicity; eliminating pathogenic cell populations; synthesis; claimed intermediates ENDOCYTE, INC. (US) 2009-10-13 US disclosed
US-20090181956-A1 Hydrazide Compound and Pesticidal Use of the Same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-16 US disclosed
WO-2007043677-A9 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME SUMITOMO CHEMICAL CO (JP) 2007-06-07 WO disclosed
WO-2007043677-A1 HYDRAZIDE COMPOUND AND PESTICIDAL USE OF THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-19 WO disclosed